Dual interaction of the malaria circumsporozoite protein with the low density lipoprotein receptor-related protein (LRP) and heparan sulfate proteoglycans

Journal of Experimental Medicine

Volumn 184, Issue 5, 1996, Pages 1699-1711

  Shakibaei, Mehdi ^a   Frevert, Ute ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR; PROTEOHEPARAN SULFATE; PROTOZOAL PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENDOCYTOSIS; HOST PARASITE INTERACTION; MALARIA; MOUSE; NONHUMAN; PLASMODIUM BERGHEI; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

EID: 0029807992     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.184.5.1699     Document Type: Article

References (54)

1. Nussenzweig, V., and R.S. Nussenzweig. 1989. Rationale for the development of an engineered sporozoite malaria vaccine. Adv. Immunol. 45:283-334.
2. Cerami, C., U. Frevert, P. Sinnis, B. Takacs, P. Clavijio, M.J. Santos, and V. Nussenzweig. 1992. The basolateral domain of the hepatocyte plasma membrane bears receptors for the circumsporozoite protein of Plasmodium falciparum sporozoites. Cell. 70:1021-1033.
3. Pancake, S.J., G.D. Holt, S. Mellouk, and S.L. Hoffman. 1992. Malaria sporozoites and circumsporozoite proteins bind specifically to sulfated glycoconjugates. J. Cell Biol. 117: 1351-1357.
4. Frevert, U., P. Sinnis, C. Cerami, W. Shreffler, B. Takacs, and V. Nussenzweig. 1993. Malaria circumsporozoite protein binds to heparan sulfate proteoglycans associated with the surface membrane of hepatocytes. J. Exp. Med. 177:1287-1298.
5. Cerami, C., U. Frevert, P. Sinnis, B. Takacs, and V. Nussenzweig. 1994. Rapid clearance of malaria circumsporozoite protein (CS) by hepatocytes. J. Exp. Med. 179:695-701.
6. Sinnis, P., P. Clavijio, D. Fenyo, B.T. Chait, C. Cerami, and V. Nussenzweig. 1994. Structural and functional properties of region II-plus of the malaria circumsporozoite protein. J. Exp. Med. 180:297-306.
7. Lyon, M., J.A. Denkin, and J.T. Gallagher. 1994. Liver heparan sulfate structure. A novel molecular design. J. Biol. Chem. 269:11208-11215.
8. Frevert, U., P. Sinnis, J.D. Esko, and V. Nussenzweig. 1996. Cell surface glycosaminoglycans are not obligatory for Plasmodium berghei sporozoite invasion in vitro. Mol. Biochem. Parasitol. 76:257-266.
9. Beisiegel, U., W. Weber, G. Ihrke, J. Herz, and K.K. Stanley. 1989. The LDL-receptor related protein, LRP, is an apolipoprotein E binding protein. Nature (Lond.). 341:162-164.
10. Willnow, T.E., J.L. Goldstein, K. Orth, M.S. Brown, and J. Herz. 1992. Low density lipoprotein receptor-related protein and gp 330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance. J. Biol. Chem. 267:26172-26180.
11. Ziere, G.J., M.C.M. Dijk, M.K. Bijsterbosch, and T.J.C. Berkel. 1992. Lactoferrin uptake by the rat liver. Characterization of the recognition site and effect of selective modification of arginine residues. J. Biol. Chem. 267:11229-11235.
12. Ji, Z.-S., W.J. Brecht, R.D. Miranda, M.M. Hussain, T.L. Innerarity, and R.W. Mahley. 1993. Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein-E-enriched remnant lipoproteins by cultured cells. J. Biol. Chem. 263:10160-10167.
13. Ji, Z.-S., D.A. Sanan, and R.W. Mahley. 1995. Intravenous heparinase inhibits remnant lipoprotein clearance from the plasma and uptake by the liver: in vivo role of heparan sulfate proteoglycans. J. Lipid Res. 36:583-592.
14. Ji, Z.-S., and R.W. Mahley. 1994. Lactoferrin binding to heparan sulfate proteoglycans and the LDL receptor-related protein. Arteriosclerosis Thrombosis 14:2025-2032.
15. Herz, J., S.-Q. Qiu, A. Oesterle, H.-V. DeSilva, S. Shafi, and R.J. Havel. 1995. Initial hepatic removal of chylomicron remnants is unaffected but endocytosis is delayed in mice lacking the low density lipoprotein receptor. Proc. Natl. Acad. Sci. USA. 92:4611-4615.
16. Krieger, M., and J. Herz. 1994. Structures and functions of multiligand lipoprotein receptors: Macrophage scavenger receptor and LDL receptor-related protein (LRP). Annu. Rev. Biochem. 63:601-637.
17. Strickland, D.K., M.Z. Kounnas, and W.S. Argraves. 1995. LDL receptor-related protein: a multiligand receptor for lipoprotein and proteinase catabolism. FASEB (Fed. Am. Soc. Exp. Biol.) J. 9:890-898.
18. Strickland, D.K., J.D. Ashcom, S.E. Williams, F. Battey, E. Behre, K. McTigue, J.F. Battey, and W.S. Argraves. 1991. Primary structure of α2-macroglobulin receptor-associated protein. Human homologue of a Heymann nephritis antigen. J. Biol. Chem. 266:13364-13369.
19. Herz, J., J.L. Goldstein, D.K. Stickland, Y.K. Ho, and M.S. Brown. 1991. 39-kDa protein modulates binding of ligands to low density lipoprotein receptor-related protein/α2-macroglobulin receptor. J. Biol. Chem. 266:21232-21238.
20. Mulder, M., P. Lombardi, H. Jansen, T.J.C. Berkel, R.R. Frants, and L.M. Havekes. 1992. Heparan sulfate proteoglycans are involved in the lipoprotein lipase-mediated enhancement of the cellular binding of very low density and low density lipoproteins. Biochem. Biophys. Res. Commun. 185:582-587.
21. Mulder, M., P. Lombardi, H. Jansen, T.J.C. Berkel, R.R. Frants, and L.M. Havekes. 1993. Low density lipoprotein receptor internalizes low density and very low density lipoproteins that are bound to heparan sulfate proteoglycans via lipoprotein lipase. J. Biol. Chem. 268:9369-9375.
22. Chappell, D.A., G.L. Fry, M.A. Waknitz, L.E. Muhonem, M.W. Pladet, P.-H. Iverius, and D.K. Strickland. 1993. Lipoprotein lipase induces catabolism of normal triglycerid-rich lipoproteins via the low density lipoprotein receptor-related protein/α2-macroglobulin receptor in vitro. J. Biol. Chem. 268:14168-14175.
23. Obunike, J.C., I.J. Edwards, S.C. Rumsey, L.K. Curtiss, W.D. Wagner, R.J. Deckelbaum, and I.J. Goldberg. 1994. Cellular differences in lipoprotein lipase-mediated uptake of low density lipoproteins. J. Biol. Chem. 269:13129-13135.
24. Kounnas, M.Z., D.A. Chappel, H. Wong, W.S. Argraves, and D.K. Strickland. 1995. The cellular internalization and degradation of hepatic lipase is mediated by low density lipoprotein receptor-related protein and requires cell surface proteoglycans. J. Biol. Chem. 270:9307-9312.
25. Kowal, R.C., J. Herz, K.H. Weisgraber, R.W. Mahley, M.S. Brown, and J.L. Goldstein. 1990. Opposing effects of apolipoproteins E and C on lipoprotein binding to LDL receptor related protein. J Biol. Chem. 265:10771-10779.
26. Sinnis, P., T.E. Willnow, M.R.S. Briones, J. Herz, and V. Nussenzweig. 1996. Remnant lipoproteins inhibit malaria sporozoite invasion of hepatocytes. J. Exp. Med. 184:945-954.
27. Ashcom, J.D., S.E. Tillerm, K. Dickerson, J.L. Cravens, W.S. Argraves, and D.K. Strickland. 1990. The human α2-macroglobulin receptor: identification of a 420 kD cell surface glycoprotein specific for the activated conformation of α2-macroglobulin. J. Cell Biol. 110:1041-1048.
28. Nardin, E.H., V. Nussenzweig, R.S. Nussenzweig, W.E. Collins, K.T. Harinasuta, P. Tapchaisri, and Y. Chomcharn. 1982. Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax. J. Exp. Med. 156: 20-30.
29. Yoshida, N., R.S. Nussenzweig, P. Potocnjak, V. Nussenzweig, and M. Aikawa. 1980. Hybridoma produces protective antibodies directed against the sporozoite stage of malaria parasite. Science (Wash. DC). 207:71-73.
30. Tsuji, M., D. Mattei, R.S. Nussenzweig, D. Eichinger, and F. Zavala. 1994. Demonstration of a heat-shock protein 70 in the sporozoite stage of malaria parasites. Parasitol. Res. 80:16-21.
31. Anderson, R.G.W., and L. Orci. 1988. A view of acidic intracellular compartments. J. Cell Biol. 106:539-543.
32. Esko, J.D., T.E. Stewart, and W.H. Taylor. 1985. Animal cell mutants defective in glycosaminoglycan biosynthesis. Proc. Natl. Acad. Sci. USA. 82:3197-3201.
33. Willnow, T. E., and J. Herz. 1994. Genetic deficiency in low density lipoprotein receptor-related protein confers cellular resistance to Pseudomonas exotoxin A: evidence that this protein is required for uptake and degradation of multiple ligands. J. Cell Sci. 107:719-726.
34. Williams, S.E., J.D. Ashcom, W.S. Argraves, and D.K. Strickland. 1992. A novel mechanism for controlling the activity of α2-macroglobulin receptor/low density lipoprotein receptor-related protein. J. Biol. Chem. 267:9035-9040.
35. Munson, P.J., and D. Rodbard. 1980. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem. 107:220-239.
36. Godyna, S., G. Liau, I. Popa, S. Stefansson, and W.S. Argraves. 1995. Identification of the low density lipoprotein receptor-related protein (LRP) as an endocytic receptor for thrombospondin-1. J. Cell Biol. 129:1403-1410.
37. Mikhailenko, I., M.Z. Kounnas, and D.K. Strickland. 1995. Low density lipoprotein receoptor-related protein/α2-macroglobulin receptor mediates the cellular internalization and degradation of thrombospondin. A process facilitated by proteoglycans. J. Biol. Chem. 270:9543-9549.
38. Mahley, R.W., Z.-S. Ji, W.J. Brecht, D. Miranda, and D. He. 1994. Role of heparan sulfate proteoglycans and the LDL receptor-related protein in remnant metabolism. Ann. NY Acad. Sci. 737:39-51.
39. Yamashiro, D.J., L.A. Borden, and F.R. Maxfield. 1989. Kinetics of α2-macroglobulin endocytosis and degradation in mutant and wild type hamster ovary cells. J. Cell. Physiol. 139:377-382.
40. Iadonato, S.P., G. Bu, E.A. Maksymovitch, and A.L. Schwartz. 1993. Interaction of a 39 kDa protein with the low-density-lipoprotein-receptor-related protein (LRP) on rat hepatoma cells. Biochem. J. 296:867-875.
41. Vassiliou, G., and K.K. Stanley. 1994. Exogenous receptor-associated protein binds to two distinct sites on human fibroblasts but does not bind to the glycosaminglycan residues of heparan sulfate proteoglycans. J. Biol. Chem. 269:15172-15178.
42. Meilinger, M., M. Haumer, K.A. Szakmary, F. Steinboek, B. Scheiber, H. Goldenberg, and M. Huettinger. 1995. Removal of lactoferrin from plasma is mediated by binding to low density lipoprotein receptor-related protein/α2-macroglobulin receptor and transport to endosomes. FEBS Lett. 360:70-74.
43. Cerami, C., F. Kwakye-Berko, and V. Nussenzweig. 1992. Binding of malarial CS protein to sulfatides [Gal(3-SO4)b1-Cer] and cholesterol-3-sulfate: dependency on disulfide bond formation between cysteines in region II. Mol. Biochem. Parasitol. 54:1-12.
44. Pantoliano, M.W., R.A. Hrlick, B.A. Springer, D.E. Van Dyk, T. Tobery, D.R. Wetmore, J.D. Lear, A.T. Nahapetian, J.D. Bradley, and W.P. Sisk. 1994. Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization. Biochemistry. 33:10229-10248.
45. Springer, B.A., M.W. Pantoliano, F.A. Barbera, P.L. Gunyuzlu, L.D. Thompson, W.F. Herblin, S.A. Rosenfeld, and G.W. Book. 1994. Identification and concerted function of two receptor binding surfaces on basic fibroblast growth factor required for mitogenesis. J. Biol. Chem. 269:26879-26884.
46. Russell, D.W., M.S. Brown, and J.L. Goldstein. 1989. Different combinations of cystein-rich repeats mediate binding of low density lipoprotein receptor of two different proteins. J. Biol. Chem. 264:21682-21688.
47. Lalazar, A., K.H. Weisgraber, S.C. Rail, H. Giladi, T.L. Innerarity, A.Z. Levanon, J.K. Boyles, B. Amit, M. Gorecki, R.W. Mahley, and T. Vogel. 1988. Site-specific mutagenesis of human apolipoprotein E. Receptor binding activity of variants with single amino acid substitutions. J. Biol. Chem. 263:3542-3545.
48. Ziere, G.J., M.K. Bijsterbosch, and T.J.C. Berkel. 1993. Removal of 14 N-terminal amino acids of lactoferrin enhances its affinity for parenchymal liver cells and potentiates the inhibition of β-very low density lipoprotein binding. J. Biol. Chem. 268:27069-27075.
49. Aley, S.B., M.D. Bates, J.P. Tam, and M.K. Hollingdale. 1986. Synthetic peptides from the circumsporozoite proteins of Plasmodium falciparum and Plasmodium knowlesi recognize the human hepatoma cell line HepG2-A16 in vitro. J. Exp. Med. 164:1915-1922.
50. Gardner, J.P., R.A. Pinches, D.J. Roberts, and C.I. Newbold. 1996. Variant antigens and endothelial receptor adhesion in Plasmodium falciparum. Proc. Natl. Acad. Sci. USA. 93: 3503-3508.
51. Baruch, D.I., J.A. Gormley, C. Ma, R.J. Howard, and B.L. Pasloske. 1996. Plasmodium falciparum erythrocyte membrane protein 1 is a parasitized erythrocyte receptor for adherence to CD36, thrombospondin, and intercellular adhesion molecule 1. Proc. Natl. Acad. Sci. USA. 93:3497-3502.
52. Hügel, F.-U., G. Pradel, and U. Frevert. 1996. Release of malaria circumsporozoite protein into the host cell cytoplasm and interaction with ribosomes. Mol. Biochem. Parasitol. In press.
53. Robson, K.J.H., U. Frevert, I. Reckmann, G. Cowan, J. Beier, I.G. Scragg, K. Takehara, D.H.L. Bishop, G. Pradel, R. Sinden et al. 1995. Thrombospondin related adhesive protein (TRAP) of Plasmodium falciparum: expression during sporozoite ontogeny and aggregate dependent binding to hepatocyte. EMBO (Eur. Mol. Biol. Organ.) J. 14:3883-3894.
54. Michishita, M., V. Videm, and M.A. Amaout. 1993. A novel divalent cation-binding site in the A domain of the b2 integrin CR3 (CD11b/CD18) is essential for ligand binding. Cell. 72:857-867.